These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Validation of cardiovascular risk scores in a liver transplant population. Guckelberger O, Mutzke F, Glanemann M, Neumann UP, Jonas S, Neuhaus R, Neuhaus P, Langrehr JM. Liver Transpl; 2006 Mar; 12(3):394-401. PubMed ID: 16498651 [Abstract] [Full Text] [Related]
3. Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. Bianchi G, Nicolino F, Passerini G, Grazi GL, Zappoli P, Graziani R, Berzigotti A, Chianese R, Mantovani V, Pinna AD, Zoli M. Liver Transpl; 2006 Jan; 12(1):105-11. PubMed ID: 16382457 [Abstract] [Full Text] [Related]
4. Adrenal failure in liver transplant patients: does steroid-free immunosuppression place recipients at risk for an adrenal crisis? Perkins J. Liver Transpl; 2006 Jan; 12(1):160-2. PubMed ID: 16498711 [No Abstract] [Full Text] [Related]
6. Liver retransplantation: report of 80 cases and review of literature. Shen ZY, Zhu ZJ, Deng YL, Zheng H, Pan C, Zhang YM, Shi R, Jiang WT, Zhang JJ. Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):180-4. PubMed ID: 16698571 [Abstract] [Full Text] [Related]
7. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [Abstract] [Full Text] [Related]
8. Liver transplantation in South Carolina. Cofer JB, Galbraith RM, Bailey M, Bromberg JS, Rajagopalan PR, Fitts CT, Conroy J, Wilson F, Crawford FA. J S C Med Assoc; 1993 Mar; 89(3):111-8. PubMed ID: 8468962 [No Abstract] [Full Text] [Related]
9. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Aalten J, Hoogeveen EK, Roodnat JI, Weimar W, Borm GF, de Fijter JW, Hoitsma AJ. Transpl Int; 2008 Oct; 21(10):985-91. PubMed ID: 18564985 [Abstract] [Full Text] [Related]
10. Chronic kidney disease: the new silent killer. Kopyt NP. J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380 [No Abstract] [Full Text] [Related]
11. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
12. Combined simultaneous heart and liver transplantation with complete cardiopulmonary bypass support. Bernier PL, Grenon M, Ergina P, Schricker T, Chaudhury P, Metrakos P, Lachapelle K. Ann Thorac Surg; 2007 Apr; 83(4):1544-5. PubMed ID: 17383383 [Abstract] [Full Text] [Related]
13. Cytomegalovirus in liver transplant recipients: there are many ways to Rome. Rayes N, Seehofer D, Neuhaus P. Liver Transpl; 2006 Feb; 12(2):326. PubMed ID: 16447200 [No Abstract] [Full Text] [Related]
14. Recurrent primary sclerosing cholangitis: from an academic illusion to a clinical reality. Abu-Elmagd KM, Balan V. Liver Transpl; 2005 Nov; 11(11):1326-8. PubMed ID: 16237700 [No Abstract] [Full Text] [Related]
15. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY. Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172 [Abstract] [Full Text] [Related]